(Sharecast News) - Alliance Pharma has reached agreement with Duchesnay of Canada to return the UK and EU licensing rights to 'Xonvea', a prescription medicine for the treatment of nausea and vomiting of pregnancy where conservative management has failed, it announced on Wednesday.
Read moreAlliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake
Read moreWednesday 18 September KingfisherHalf Year ResultsAccesso TechnologyHalf Year Year Year
Read moreThursday 11 July Kenmare ResourcesHalf Year ProductionMcBrideTrading GroupFull
Read more(Alliance News) - Alliance Pharma PLC said on Monday founder & former chief executive John Dawson decided to step down from the board.Dawson, who was a non-executive director at the on
Read moreFriday 17 MayRestaurant GroupBank of Georgia GroupCentaur MediaCairn Continental 20
Read more(Sharecast News) - Alliance Pharma announced on Wednesday that 'Xonvea' has gained marketing approval in the Republic of Ireland from the country's medicines regulator, the Health Products Regulatory Authority, for the treatment of nausea and vomiting of pregnancy where conservative management has failed.
Read moreLONDON (Alliance News) - Alliance Pharma PLC on Wednesday said its Xonvea drug has been approved in Ireland to treat nausea and vomiting of pregnancy.The Irish marketing approval is first
Read moreLONDON (Alliance News) - Alliance Pharma on Tuesday raised its dividend for 2018 amid a strong revenue performance, though profit fell due to impairments.The pharmaceutical retailer said to
Read moreWednesday 20 March KingfisherFull Year ResultsCentaur MediaFull Year GroupHalf
Read more(Sharecast News) - Alliance Pharma on Monday reported a jump in revenue after a strong performance from its 'star' products and newly acquired Nizoral brand.
Read moreTuesday 15 January Boohoo GroupTrading Statement Gym GroupTrading Workshop Year Year
Read more(Sharecast News) - Alliance Pharma launched its prescription product for the treatment of nausea and vomiting of pregnancy across the UK on Tuesday.
Read moreLONDON (Alliance News) - Strategic Equity Capital PLC said on Monday it underperformed against its benchmark for its recently ended financial year, due to an undervalued portfolio.The said
Read more